Get the Stockscreener App
3.72
4.49%
0.16
Bioaffinity Technologies Inc stock is traded at $3.72, with a volume of 92,928.
It is up +4.49% in the last 24 hours and down -41.51% over the past month.
bioAffinity Technologies Inc develops noninvasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis informed by machine learning, a form of artificial intelligence (AI). Its first commercial diagnostic test, CyPath Lung, identifies and analyzes cell populations using flow cytometry, including cancer and cancer-related cells, that indicate a malignancy in the lung. It is developing its flow cytometry platform to address the need to identify patients who can benefit from new and emerging therapies for asthma and chronic obstructive pulmonary disease with noninvasive precision diagnostic tests. The company is organized in two operating segments, Diagnostic Research and Development and Laboratory Services.
See More
Previous Close:
$3.56
Open:
$3.47
24h Volume:
92,928
Relative Volume:
0.02
Market Cap:
$2.23M
Revenue:
$5.66M
Net Income/Loss:
$-15.88M
P/E Ratio:
-0.3288
EPS:
-11.3134
Net Cash Flow:
$-10.93M
1W Performance:
-34.04%
1M Performance:
-41.51%
6M Performance:
-91.54%
1Y Performance:
-90.85%
1-Day Range:
$3.4063
$3.72
1-Week Range:
$3.23
$5.4802
52-Week Range:
$3.23
$80.70
Bioaffinity Technologies Inc Stock (BIAF) Company Profile
Name
Bioaffinity Technologies Inc
Sector
Industry
Phone
210-698-5334
Address
3300 NACOGDOCHES ROAD, SAN ANTONIO
Compare BIAF vs TMO, DHR, NTRA, A, IQV
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BIAF
Bioaffinity Technologies Inc
|
3.72 | 2.23M | 5.66M | -15.88M | -10.93M | -11.31 |
TMO
Thermo Fisher Scientific Inc
|
693.35 | 256.36B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
231.68 | 162.87B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
402.42 | 58.01B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
176.41 | 49.74B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
269.96 | 44.44B | 16.63B | 1.39B | 2.12B | 8.0674 |
Bioaffinity Technologies Inc Stock (BIAF) Latest News
Form 424B5 bioAffinity Technologies Inc For: 10 October By Investing.com - Investing.com Canada
bioAffinity Technologies closes $4M stock offering on Nasdaq - StreetInsider
bioAffinity Technologies plans $4M stock offering on Nasdaq - StreetInsider
bioAffinity Technologies, Inc. Announces Approximately $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules - Business Wire
Japan intends to grant a patent for a home-collected lung cancer risk test - Stock Titan
More than 1,620 tests to assess lung cancer risk were delivered through Q3 2026. - Stock Titan
Shares could be offered up to 35% below market; bioAffinity Technologies (BIAF) seeks a stockholder vote. - Stock Titan
BIAF Historical Stock Prices & Daily Price Data | bioAffinity Technologies, Inc. Common - Quiver Quantitative
Form 8K bioAffinity Technologies Inc For: 22 September By Investing.com - Investing.com Nigeria
A 2,000-patient study is evaluating a lung cancer test using at-home samples. - Stock Titan
BIAF Stock Soars As Hong Kong Patent Ignites Trading - stockstotrade.com
BIAF Stock Jolts Higher On Nasdaq Win And Federal Deal - stockstotrade.com
bioAffinity Gets Hong Kong Patent for CyPath Lung Test | BIAF Stock News - Stock Titan
bioAffinity Technologies at H.C. Wainwright conference: lung test gains traction - Investing.com Canada
bioAffinity Technologies at H.C. Wainwright conference: lung test gains traction - Investing.com India
bioAffinity Technologies at H.C. Wainwright conference: lung test gains traction - Investing.com UK
BioAffinity Technologies (NASDAQ: BIAF) Announces Presentation Materials for 2026 H.C. Wainwright Global Investment Conference - Kalkine Media
Why Did bioAffinity (NASDAQ:BIAF) Regain Nasdaq Compliance? - Kalkine Media
bioAffinity Regains Nasdaq Compliance, Maintains Capital Market Listing - The Globe and Mail
bioAffinity Regains Nasdaq Compliance, Maintains Capital Market Listing - The Globe and Mail
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
bioAffinity Technologies shares rise after Nasdaq compliance update - Quiver Quantitative
Monday's Gap-Up and Gap-Down Stock Movers: September 8 - ChartMill
BIAF Stock Jumps As Federal Deal Fuels CyPath Lung Momentum - timothysykes.com
bioAffinity Technologies regains Nasdaq compliance after bid-price recovery - TradingView
BIAF Stock Pops As CyPath Lung Wins Federal Distribution - StocksToTrade
Congrats to the folks who joined at $10. Don't forget to give me a like 😘 - Moomoo
bioAffinity Technologies Regains Compliance with Nasdaq Listing Requirements - Yahoo Finance UK
bioAffinity Technologies Regains Compliance with Nasdaq Listing Requirements - Business Wire
bioAffinity Technologies Regains Compliance with Nasdaq Listing Requirements - FinancialContent
Monday's Gap-Up and Gap-Down Stock Movers: September 8 - ChartMill
Top Small Cap Stocks To ConsiderSeptember 7th - MarketBeat
Small Cap Stocks To Follow NowSeptember 5th - MarketBeat
BIAF Stock Slides As bioAffinity’s Dilution And Reverse Split Reshape Trading Setup - stockstotrade.com
bioAffinity’s AI Lung-Cancer Stock Jumped Nearly 48% After a Reverse Split. What Would Have to Go Right? - Yahoo Finance
bioAffinity Technologies to Present Corporate Update at Conference - The Globe and Mail
AOUT, NX, and BIAF stocks soar on strong earnin... - pluang.com
bioAffinity Technologies Inc. Warrant (BIAFW) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
$15.5 to $19.35 🫡 - Moomoo
You know I'm drunk, so my words carry extra weight 😘 - Moomoo
bioAffinity Technologies to Present Corporate Update at Conference - TipRanks
bioAffinity Technologies to Present Corporate Update at H.C. Wainwright Conference; Market Cap ~$5.9M - TradingView
bioAffinity Technologies to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - Yahoo Finance
bioAffinity Technologies and AvMEDICAL Announce Nationwide Federa - The National Law Review
Biotech Stocks To Follow NowSeptember 3rd - MarketBeat
BIAF Stock Pops As Federal Lung Test Deal Fuels Momentum - timothysykes.com
BIAF Stock Jumps As Federal Deal Fuels Lung Test Growth - StocksToTrade
bioAffinity Technologies Shares Rise After CyPath Lung Surveillance Update - Yahoo Finance
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Bioaffinity Technologies Inc Stock (BIAF) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.96%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):